RMFCX | VECRX | RMFCX / VECRX | |
Total Expense Ratio | 0.91 | 0.78 | 117% |
Annual Report Gross Expense Ratio | 0.91 | 1.04 | 88% |
Fund Existence | 23 years | 8 years | - |
Gain YTD | 12.767 | 10.830 | 118% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 250 | 2500000 | 0% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 110B | 137M | 80,292% |
Annual Yield % from dividends | 1.24 | 2.80 | 44% |
Returns for 1 year | 7.96 | 9.61 | 83% |
Returns for 3 years | 32.87 | 22.96 | 143% |
Returns for 5 years | 60.22 | 9.19 | 655% |
Returns for 10 years | 93.48 | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
VNSNX | 24.74 | -0.06 | -0.24% |
Natixis Vaughan Nelson Select N | |||
EPIVX | 13.71 | -0.05 | -0.36% |
EuroPac International Value A | |||
LVAFX | 11.80 | -0.07 | -0.59% |
LSV Global Managed Volatility Investor | |||
HHDFX | 37.24 | -0.23 | -0.61% |
Hamlin High Dividend Equity Instl | |||
SHSCX | 46.99 | -0.52 | -1.09% |
BlackRock Health Sciences Opps Inv C |